New hope for Hard-to-Treat leukemia? early trial launches
Disease control
Not yet recruiting
This early-stage study tests a new drug called CT0991 in 24 adults with acute myeloid leukemia that has come back or not responded to treatment. The main goals are to check safety, find the right dose, and see if it helps control the disease. Participants must be between 18 and 7…
Phase: PHASE1 • Sponsor: MEI HENG • Aim: Disease control
Last updated May 13, 2026 16:03 UTC